2024 universal registration document

Note 25 Changes in other financial assets

This caption mainly comprises long-term investments with the Group's cash pool.

Note 26 Net cash and cash equivalents

Cash and cash equivalents can be broken down as follows:

Note 27 Other information

Statutory audit fees are presented in note 16 to the consolidated financial statements.

Note 28 Subsequent events

Signing of an agreement for the sale of 2.3% of Sanofi shares

The L'Oréal Groupe announced on 3 February 2025 the signing of an agreement for the sale of approximately 29.6 million Sanofi shares to Sanofi at a price of €101.5 per share, i.e., a total consideration of €3 billion. Following completion of the transaction and cancellation of the shares bought back, L'Oréal will hold 7.2% of Sanofi's share capital and 13.1% of the voting rights⁽¹⁾.

The transaction, which will be carried out through an off-market block trade, is not subject to any condition precedent and should be finalized in the coming days.

Note 29 Table of subsidiaries and equity investments

DETAILED INFORMATION